Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.72% slid 1.20% to $168.37 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.21% rising 0.15% to 34,987.02 and the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.28% falling 0.33% to 4,360.03. Johnson & Johnson closed $5.28 short of its 52-week high ($173.65), which the company achieved on January 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF +0.81% fell 2.23% to $380.91, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -0.34% rose 0.36% to $77.90, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.84% rose 0.35% to $40.09. Trading volume (6.6 M) eclipsed its 50-day average volume of 6.4 M.